SayPro to progress towards clinical validation innovative technologies necessary for making biomarker(s) accessible for clinical use. In proposals focusing uniquely on these technologies, applicants should justify how such progress will enable the validation of the biomarker(s) for use in a clinical context.

South African rand (R) - ZAR
  • South African rand (R) - ZAR
  • United States dollar ($) - USD
  • Euro (€) - EUR

Description

Reviews

There are no reviews yet.

Be the first to review “SayPro to progress towards clinical validation innovative technologies necessary for making biomarker(s) accessible for clinical use. In proposals focusing uniquely on these technologies, applicants should justify how such progress will enable the validation of the biomarker(s) for use in a clinical context.”

Vendor Information

  • No ratings found yet!

SayPro to progress towards clinical validation innovative technologies necessary for making biomarker(s) accessible for clinical use. In proposals focusing uniquely on these technologies, applicants should justify how such progress will enable the validation of the biomarker(s) for use in a clinical context.

South African rand (R) - ZAR
  • South African rand (R) - ZAR
  • United States dollar ($) - USD
  • Euro (€) - EUR

Description

Reviews

There are no reviews yet.

Be the first to review “SayPro to progress towards clinical validation innovative technologies necessary for making biomarker(s) accessible for clinical use. In proposals focusing uniquely on these technologies, applicants should justify how such progress will enable the validation of the biomarker(s) for use in a clinical context.”

Vendor Information

  • No ratings found yet!